Since 2014, Semaglutide GLP-1 injections have been FDA-approved for use as a means to supplement weight loss for those who are obese or who suffer from weight-related medical problems
I really appreciated the effort
A broader review of real-world evidence puts first-year discontinuation across studies in the range of 20% to 50%, with real-world weight outcomes generally falling below trial results, except among the most adherent patients, whose outcomes approach what trials reported
Its exclusive Nu-V treatment has garnered significant media attention and has been featured in mainstream UK outlets for some time
Ozempic, Mounjaro, Wegovy and similar drugs are GLP-1 receptor agonists, synthetic versions of that natural hormone
But given their high prices a month's supply of Wegovy costs $1,350 (1,062) and onerous side effects which can include nausea, stomach pain and heartburn, the question has always been, what happens when people stop taking them